These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2191259)

  • 21. Bronchopulmonary dysplasia.
    Deakins KM
    Respir Care; 2009 Sep; 54(9):1252-62. PubMed ID: 19712501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quercetin attenuates the hyperoxic lung injury in neonatal mice: Implications for Bronchopulmonary dysplasia (BPD).
    Maturu P; Wei-Liang Y; Androutsopoulos VP; Jiang W; Wang L; Tsatsakis AM; Couroucli XI
    Food Chem Toxicol; 2018 Apr; 114():23-33. PubMed ID: 29432836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacological prophylaxis and treatment of bronchopulmonary dysplasia].
    Groneck P; Speer CP
    Z Geburtshilfe Neonatol; 2005 Aug; 209(4):119-27. PubMed ID: 16138269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [TREATMENT OF EXTREMELY PREMATURE NEWBORN INFANT WITH INO. CLINICAL CASE].
    Radulova P; Slancheva B; Marinov R
    Akush Ginekol (Sofiia); 2015; 54(9):52-7. PubMed ID: 26863798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia.
    Jiang Q; Gao X; Liu C; Chen D; Lin X; Xia S; Zhuang D; Yang C; Zhu W; Liu L; Chen C; Sun B
    J Perinatol; 2016 Oct; 36(10):883-9. PubMed ID: 27442155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.
    D'Angio CT; Maniscalco WM
    Paediatr Drugs; 2004; 6(5):303-30. PubMed ID: 15449969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled salbutamol and beclomethasone for preventing broncho-pulmonary dysplasia: a randomised double-blind study.
    Denjean A; Paris-Llado J; Zupan V; Debillon T; Kieffer F; Magny JF; Desfrères L; Llanas B; Guimaraes H; Moriette G; Voyer M; Dehan M; Breart G
    Eur J Pediatr; 1998 Nov; 157(11):926-31. PubMed ID: 9835439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of bronchopulmonary dyplasia (BPD).
    Am J Respir Crit Care Med; 2014 Apr; 189(8):P13-4. PubMed ID: 24735043
    [No Abstract]   [Full Text] [Related]  

  • 30. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia.
    Kugelman A; Durand M; Garg M
    Pediatrics; 1997 Jan; 99(1):71-5. PubMed ID: 8989341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunctive pharmacotherapy in neonates with respiratory failure.
    Fok TF
    Semin Fetal Neonatal Med; 2009 Feb; 14(1):49-55. PubMed ID: 18851933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tracheomalacia in bronchopulmonary dysplasia: Trachealis hyper-relaxant responses to S-nitrosoglutathione in a hyperoxic murine model.
    Einisman HJ; Gaston B; Wijers C; Smith LA; Lewis TH; Lewis SJ; Raffay TM
    Pediatr Pulmonol; 2019 Dec; 54(12):1989-1996. PubMed ID: 31486289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surfactant, steroids and non-invasive ventilation in the prevention of BPD.
    Dumpa V; Bhandari V
    Semin Perinatol; 2018 Nov; 42(7):444-452. PubMed ID: 30343941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
    Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug treatment for bronchopulmonary dysplasia in Japan: questionnaire survey.
    Ogawa R; Mori R; Sako M; Kageyama M; Tamura M; Namba F
    Pediatr Int; 2015; 57(1):189-92. PubMed ID: 25711265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Office management of bronchopulmonary dysplasia.
    Daigle KL; Cloutier MM
    Compr Ther; 1997 Oct; 23(10):656-62. PubMed ID: 9327181
    [No Abstract]   [Full Text] [Related]  

  • 37. Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia.
    Motoyama EK; Fort MD; Klesh KW; Mutich RL; Guthrie RD
    Am Rev Respir Dis; 1987 Jul; 136(1):50-7. PubMed ID: 3605840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aerosolized furosemide in the treatment of acute respiratory distress and possible bronchopulmonary dysplasia in preterm neonates.
    Pai VB; Nahata MC
    Ann Pharmacother; 2000 Mar; 34(3):386-92. PubMed ID: 10917388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of bronchodilator response by forced oscillation technique in a preterm infant with evolving bronchopulmonary dysplasia: A case report.
    Rigotti C; Zannin E; Abdelfattah AS; Ventura ML; Dellacà RL
    Pediatr Pulmonol; 2022 Apr; 57(4):1092-1095. PubMed ID: 34970872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of oral diuretics on pulmonary mechanics in infants with chronic bronchopulmonary dysplasia: results of a double-blind crossover sequential trial.
    Kao LC; Warburton D; Cheng MH; Cedeño C; Platzker AC; Keens TG
    Pediatrics; 1984 Jul; 74(1):37-44. PubMed ID: 6377221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.